BioXcel Therapeutics reported revenue of $0.18M and net income of -$14.71M for the quarter ended Jun 2026, up 51.7% year over year. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.75M | 1.75M | 1.75M | 1.75M | 1.75M | 1.76M | 1.82M | 1.83M | 1.83M | 1.87M | 2.10M | 2.52M | 2.65M | 2.54M | 5.47M | 6.62M | 14.20M | 12.21M | 27.07M | 31.30M | ||||||||||||||||||
| Revenue & cost | ||||||||||||||||||||||||||||||||||||||
| Revenue | 0.14M | 0.24M | 0.21M | 0.46M | 0.34M | 0.38M | 0.58M | 1.10M | 0.21M | 0.37M | 0.17M | 0.12M | 0.10M | 0.26M | 0.21M | 0.18M | ||||||||||||||||||||||
| Gross Profit | 0.13M | 0.23M | 0.20M | 0.43M | -0.17M | -0.34M | 0.50M | 1.04M | -0.96M | -0.47M | 0.15M | 0.01M | 0.09M | 0.22M | -0.08M | 0.16M | ||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||||||||||||||
| Research & DevelopmentR&D | 11.93M | 12.53M | 18.56M | 17.91M | 22.06M | 32.46M | 27.80M | 26.97M | 19.62M | 9.93M | 11.40M | 8.03M | 5.10M | 5.90M | 4.55M | 10.26M | 8.74M | 6.70M | 2.96M | 3.16M | ||||||||||||||||||
| Selling, General & AdministrativeSG&A | 14.88M | 13.61M | 12.92M | 18.38M | 17.05M | 20.66M | 23.59M | 25.87M | 24.34M | 9.60M | 13.26M | 9.45M | 7.68M | 4.09M | 5.70M | 5.61M | 5.38M | 3.81M | 7.19M | 7.19M | ||||||||||||||||||
| Restructuring CostsRestructuring | 4.16M | 0.86M | 1.55M | 0.03M | 0.19M | |||||||||||||||||||||||||||||||||
| Other Operating ExpensesOther Opex | 0.01M | 0.01M | 0.01M | 0.03M | 0.51M | 0.71M | 0.08M | 0.06M | 1.17M | 0.83M | 0.01M | 0.11M | 0.01M | 0.03M | 0.28M | 0.02M | ||||||||||||||||||||||
| Operating ExpensesOpex | 26.81M | 26.13M | 31.48M | 36.29M | 39.13M | 53.13M | 51.40M | 52.87M | 48.64M | 20.25M | 24.75M | 18.40M | 15.51M | 10.86M | 10.27M | 15.97M | 14.33M | 10.54M | 10.43M | 10.38M | ||||||||||||||||||
| Operating IncomeOp. Inc | -26.81M | -26.13M | -31.48M | -36.29M | -38.99M | -52.89M | -51.20M | -52.41M | -48.30M | -19.88M | -24.16M | -17.30M | -15.29M | -10.49M | -10.10M | -15.85M | -14.23M | -10.28M | -10.22M | -10.19M | ||||||||||||||||||
| EBIT | -26.81M | -26.13M | -31.48M | -36.29M | -38.99M | -52.89M | -51.20M | -52.41M | -48.30M | -19.88M | -24.16M | -17.30M | -15.29M | -10.49M | -10.10M | -15.85M | -14.23M | -10.28M | -10.22M | -10.19M | ||||||||||||||||||
| Non-operating items | ||||||||||||||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.01M | 0.01M | 1.59M | 3.70M | 2.92M | 3.37M | 3.26M | 3.25M | 3.44M | 3.61M | 3.70M | 3.79M | 4.03M | 3.99M | 4.22M | 4.37M | 4.40M | 4.20M | 4.26M | ||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.05M | 0.01M | 0.20M | 0.82M | 1.49M | 2.02M | 1.62M | 1.07M | 0.95M | 0.95M | 0.67M | 0.62M | 0.37M | 0.28M | 0.23M | 0.24M | 0.32M | 0.21M | 0.13M | ||||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.06M | -0.48M | -0.25M | 0.54M | -0.01M | 0.11M | 0.03M | 12.03M | 4.82M | 3.30M | 6.56M | 0.66M | -12.55M | 1.81M | 1.52M | -0.39M | ||||||||||||||||||||||
| Non Operating IncomeNon Op. Inc. | 0.06M | |||||||||||||||||||||||||||||||||||||
| Net income details | ||||||||||||||||||||||||||||||||||||||
| EBT | -26.82M | -26.09M | -31.47M | -37.67M | -41.87M | -54.33M | -52.55M | -54.05M | -50.48M | -22.36M | -26.82M | -20.32M | -18.47M | -14.16M | -13.81M | -19.84M | -18.36M | -14.36M | -14.21M | -14.32M | ||||||||||||||||||
| Profit After TaxPAT | -26.81M | -26.12M | -31.47M | -37.67M | -41.80M | -54.81M | -52.80M | -53.52M | -50.49M | -22.26M | -26.79M | -8.30M | -13.65M | -10.86M | -7.25M | -19.19M | -30.91M | -12.54M | -12.69M | -14.71M | ||||||||||||||||||
| Income from Continuing OperationsIncome (Continuing) | -26.82M | -26.09M | -31.47M | -37.67M | -41.87M | -54.33M | -52.55M | -54.05M | -50.48M | -22.36M | -26.82M | -20.32M | -18.47M | -14.16M | -13.81M | -19.84M | -18.36M | -14.36M | -14.21M | -14.32M | ||||||||||||||||||
| Consolidated Net IncomeConsol Net Inc. | -26.82M | -26.09M | -31.47M | -37.67M | -41.87M | -54.33M | -52.55M | -54.05M | -50.48M | -22.36M | -26.82M | -20.32M | -18.47M | -14.16M | -13.81M | -19.84M | -18.36M | -14.36M | -14.21M | -14.32M | ||||||||||||||||||
| Income towards Parent CompanyParent Net Inc | -26.82M | -26.09M | -31.47M | -37.67M | -41.87M | -54.33M | -52.55M | -54.05M | -50.48M | -22.36M | -26.82M | -20.32M | -18.47M | -14.16M | -13.81M | -19.84M | -18.36M | -14.36M | -14.21M | -14.32M | ||||||||||||||||||
| Net Income towards Common StockholdersNet Income | -26.82M | -26.09M | -31.47M | -37.67M | -41.87M | -54.33M | -52.55M | -54.05M | -50.48M | -22.36M | -26.82M | -20.32M | -18.47M | -14.16M | -13.81M | -19.84M | -18.36M | -14.36M | -14.21M | -14.32M | ||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||||||||||||
| EPS (Basic) | -15.34 | -15.83 | -18.00 | -21.53 | -23.91 | -31.03 | -29.38 | -29.63 | -27.60 | -12.28 | -13.90 | -8.08 | -6.97 | -5.58 | -2.86 | -2.53 | -1.29 | -1.18 | -0.60 | -0.47 | ||||||||||||||||||
| EPS (Diluted) | -15.34 | -15.83 | -18.00 | -21.53 | -23.91 | -31.03 | -29.38 | -29.63 | -27.60 | -12.28 | -13.90 | -8.08 | -6.97 | -5.58 | -2.86 | -2.53 | -1.29 | -1.18 | -0.60 | -0.47 | ||||||||||||||||||
| Shares Outstanding | 1.75M | 1.65M | 1.75M | 1.75M | 1.75M | 1.75M | 1.79M | 1.82M | 1.83M | 1.82M | 1.93M | 2.52M | 2.65M | 2.54M | 4.83M | 7.84M | 14.20M | 12.21M | 23.57M | 30.30M | ||||||||||||||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.75M | 1.65M | 1.75M | 1.75M | 1.75M | 1.75M | 1.79M | 1.82M | 1.83M | 1.82M | 1.93M | 2.52M | 2.65M | 2.54M | 4.83M | 7.84M | 14.20M | 12.21M | 23.57M | 30.30M | ||||||||||||||||||
| EBITDA | -26.81M | -26.13M | -31.48M | -36.29M | -38.99M | -52.89M | -51.20M | -52.41M | -48.30M | -19.88M | -24.16M | -17.30M | -15.29M | -10.49M | -10.10M | -15.85M | -14.23M | -10.28M | -10.22M | -10.19M | ||||||||||||||||||
| Interest ExpensesInt Expense | 0.01M | 0.01M | 0.01M | 1.59M | 3.70M | 2.92M | 3.37M | 3.26M | 3.25M | 3.44M | 3.61M | 3.70M | 3.79M | 4.03M | 3.99M | 4.22M | 4.37M | 4.40M | 4.20M | 4.26M |